The AP-1 family of transcription factors has been implicated in the highly migratory phenotype of lung cancer cells [19], [20], [21], and two functional AP-1 binding sites or TREs have been identified in the BLIMP1 promoter [47]. The gene discussed is PRDM1; the disease is lung carcinoma.